Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370088 | 1.00 | MEN1 (0.47) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL28239484 | 0.93 | MAPT (0.44) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL8560961 | 0.88 | MEN1 (0.47) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL1451331 | 0.86 | KDM4E (0.51) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL14982069 | 0.85 | MAPT (0.53) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL27985311 | 0.84 | MEN1 (0.46) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL29362119 | 0.84 | BLM (0.45) | MEN1KMT2ASMN1; SMN2ALDH1A1HPGD | |
| SCHEMBL27985312 | 0.82 | MEN1 (0.51) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL28360413 | 0.82 | TDP1 (0.48) | KMT2AL3MBTL1ALDH1A1HPGDHTT | |
| SCHEMBL28076225 | 0.82 | AKR1C3 (0.49) | MEN1KMT2ASMN1; SMN2L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121570375-A | Application of DHHB-producing microorganism in daily chemical products | 江南大学 | 2026-02-27 | — | — | CN | claimed |
| EP-2701670-B1 | CLEAR WET SUN-CARE SPRAYS AND GELS | ISP INVESTMENTS LLC (US) | 2021-10-20 | — | — | EP | claimed |
| EP-3128993-B1 | MIXTURES OF COSMETIC UV ABSORBERS | BASF SE (DE) | 2020-08-26 | — | — | EP | claimed |
| EP-3227016-B1 | MICROCAPSULES | BASF SE (DE) | 2020-08-26 | — | — | EP | claimed |
| EP-3107526-B1 | TOPICAL ANHYDROUS FILL FORMULATION FOR ULTRAVIOLET FILTERS | SCHERER TECHNOLOGIES LLC R P (US) | 2020-07-29 | — | — | EP | claimed |
| EP-2484339-B1 | OIL-IN-WATER-TYPE EMULSION COMPOSITION | SHISEIDO CO LTD (JP) | 2016-11-23 | — | — | EP | claimed |
| EP-1728816-B1 | Method of activating the shrink characteristic of a film | CRYOVAC INC (US) | 2010-12-22 | — | — | EP | claimed |
| CN-121570375-A | Application of DHHB-producing microorganism in daily chemical products | 江南大学 | 2026-02-27 | — | — | CN | disclosed |
| EP-4540223-A1 | METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | BASF SE (DE) | 2025-04-23 | — | — | EP | disclosed |
| CN-119497614-A | Compositions and formulations for preventing, treating and ameliorating skin diseases, conditions and disorders using PK inhibitors | 德慕拜昂生物科技公司 | 2025-02-21 | — | — | CN | disclosed |
| WO-2024027193-A1 | SKIN-CARE PRODUCT COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING SULFONATED CALIXARENE, AND USE OF SULFONATED CALIXARENE | 苏州隽德生物科技有限公司 | 2024-02-08 | — | — | WO | disclosed |
| US-20240025841-A1 | METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | BASF SE (DE) | 2024-01-25 | — | — | US | disclosed |
| WO-2023242181-A1 | METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | BASF SE (DE) | 2023-12-21 | — | — | WO | disclosed |
| US-20120156149-A1 | Sunscreen Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120093747-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | ADEKA CORPORATION (JP) | 2012-04-19 | — | — | US | disclosed |
| EP-2412365-A1 | SUNSCREEN COSMETIC | Shiseido Co., Ltd. (JP) | 2012-02-01 | — | — | EP | disclosed |
| WO-2011039790-A1 | OIL-IN-WATER-TYPE EMULSION COMPOSITION | 株式会社資生堂 (JP) | 2011-04-07 | — | — | WO | disclosed |
| EP-2027847-A1 | SUNSCREEN PREPARATIONS | Shiseido Company, Limited (JP) | 2009-02-25 | — | — | EP | disclosed |
| EP-1977730-A1 | SUNSCREEN COSMETICS | SHISEIDO COMPANY, LTD. (JP) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007077729-A1 | SUNSCREEN COSMETICS | SHISEIDO COMPANY, LTD. (JP) | 2007-07-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120093747-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | CYP8B1, TYR, ERCC5 | MEN1 1059/4885KMT2A 3556/4885SMN1; SMN2 4495/4885 |
| US-20240025841-A1 | METHOD FOR OBTAINING CRYSTALLINE DIETHYLAMINO HYDROXYBENZOYL HEXYL BENZOATE | HDHD5, APEH, ABHD6 | MEN1 4641/4885KMT2A 2700/4885SMN1; SMN2 4504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.